JOEL ACKERMAN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOEL ACKERMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOEL ACKERMAN. JOEL ACKERMAN is Chief Executive Officer in CHAMPIONS ONCOLOGY, INC. ($CSBR) and Director in CHAMPIONS ONCOLOGY, INC. ($CSBR) and CFO and Treasuer in DAVITA INC. ($DVA) and Chief Financial Officer in DAVITA INC. ($DVA) and Director in KINDRED HEALTHCARE, INC ($KND) and Director in MEDICAL STAFFING NETWORK HOLDINGS INC ($MRN).
Latest Insider Trading Transactions of JOEL ACKERMAN
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CSBR, DVA, KND, MRN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 18 2021 | DVA | DAVITA INC. | ACKERMAN JOEL | CFO and Treasuer | Payment of Exercise | F | 125.41 | 8,272 | 1,037,392 | 73,260 | 81.5 K to 73.3 K (-10.15 %) |
| May 18 2021 | DVA | DAVITA INC. | ACKERMAN JOEL | CFO and Treasuer | Payment of Exercise | F | 125.41 | 1,419 | 177,957 | 81,532 | 83 K to 81.5 K (-1.71 %) |
| May 18 2021 | DVA | DAVITA INC. | ACKERMAN JOEL | CFO and Treasuer | Payment of Exercise | F | 125.41 | 2,756 | 345,630 | 82,951 | 85.7 K to 83 K (-3.22 %) |
| May 18 2021 | DVA | DAVITA INC. | ACKERMAN JOEL | CFO and Treasuer | Payment of Exercise | F | 125.41 | 11,180 | 1,402,084 | 85,707 | 96.9 K to 85.7 K (-11.54 %) |
| May 18 2021 | DVA | DAVITA INC. | ACKERMAN JOEL | CFO and Treasuer | Payment of Exercise | F | 125.41 | 712 | 89,292 | 96,887 | 97.6 K to 96.9 K (-0.73 %) |
| Apr 21 2021 | DVA | DAVITA INC. | ACKERMAN JOEL | CFO and Treasuer | Grant | A | 0.00 | 2,899 | 0 | 97,599 | 94.7 K to 97.6 K (+3.06 %) |
| Apr 21 2021 | DVA | DAVITA INC. | ACKERMAN JOEL | CFO and Treasuer | Grant | A | 0.00 | 1,456 | 0 | 94,700 | 93.2 K to 94.7 K (+1.56 %) |
| Mar 17 2021 | DVA | DAVITA INC. | ACKERMAN JOEL | CFO and Treasuer | Option Exercise | A | 108.93 | 44,065 | 4,800,000 | 44,065 | |
| Mar 17 2021 | DVA | DAVITA INC. | ACKERMAN JOEL | CFO and Treasuer | Option Exercise | A | 108.93 | 44,065 | 4,800,000 | 44,065 | |
| Mar 01 2021 | DVA | DAVITA INC. | ACKERMAN JOEL | CFO and Treasuer | Grant | A | 0.00 | 16,894 | 0 | 93,244 | 76.4 K to 93.2 K (+22.13 %) |
| Mar 01 2021 | DVA | DAVITA INC. | ACKERMAN JOEL | CFO and Treasuer | Grant | A | 0.00 | 22,832 | 0 | 76,350 | 53.5 K to 76.4 K (+42.66 %) |
| Dec 21 2020 | DVA | DAVITA INC. | ACKERMAN JOEL | CFO and Treasuer | Payment of Exercise | F | 115.36 | 4,890 | 564,110 | 53,518 | 58.4 K to 53.5 K (-8.37 %) |
| Dec 10 2020 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Director | Option Exercise | A | 11.96 | 16,667 | 199,337 | 16,667 | |
| Nov 03 2020 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Director | Option Exercise | M | 4.80 | 2,708 | 12,998 | 0 | |
| Nov 03 2020 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Director | Option Exercise | M | 5.76 | 124,232 | 715,576 | 0 | |
| Nov 03 2020 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Director | Buy | M | 4.80 | 2,708 | 12,998 | 1,443,928 | 1.4 M to 1.4 M (+0.19 %) |
| Nov 03 2020 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Director | Buy | M | 5.76 | 124,232 | 715,576 | 1,441,220 | 1.3 M to 1.4 M (+9.43 %) |
| May 19 2020 | DVA | DAVITA INC. | ACKERMAN JOEL | CFO and Treasuer | Payment of Exercise | F | 79.25 | 425 | 33,681 | 58,408 | 58.8 K to 58.4 K (-0.72 %) |
| May 19 2020 | DVA | DAVITA INC. | ACKERMAN JOEL | CFO and Treasuer | Grant | A | 0.00 | 1,116 | 0 | 58,833 | 57.7 K to 58.8 K (+1.93 %) |
| Mar 17 2020 | DVA | DAVITA INC. | ACKERMAN JOEL | CFO and Treasuer | Option Exercise | A | 75.95 | 78,999 | 5,999,974 | 78,999 | |
| Dec 04 2019 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Director | Option Exercise | M | 2.10 | 1,521 | 3,194 | 0 | |
| Dec 04 2019 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Director | Option Exercise | M | 2.10 | 201,590 | 423,339 | 0 | |
| Dec 04 2019 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Director | Buy | M | 2.10 | 1,521 | 3,194 | 1,316,988 | 1.3 M to 1.3 M (+0.12 %) |
| Dec 04 2019 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Director | Buy | M | 2.10 | 201,590 | 423,339 | 1,315,467 | 1.1 M to 1.3 M (+18.10 %) |
| Nov 06 2019 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Director | Option Exercise | A | 5.43 | 16,667 | 90,502 | 16,667 | |
| Jun 21 2019 | DVA | DAVITA INC. | ACKERMAN JOEL | CFO and Treasuer | Option Exercise | A | 52.41 | 110,000 | 5,765,100 | 110,000 | |
| Jun 21 2019 | DVA | DAVITA INC. | ACKERMAN JOEL | CFO and Treasuer | Payment of Exercise | F | 0.00 | 6,014 | 0 | 57,717 | 63.7 K to 57.7 K (-9.44 %) |
| Jun 21 2019 | DVA | DAVITA INC. | ACKERMAN JOEL | CFO and Treasuer | Grant | A | 0.00 | 22,601 | 0 | 63,731 | 41.1 K to 63.7 K (+54.95 %) |
| May 17 2019 | DVA | DAVITA INC. | ACKERMAN JOEL | Chief Financial Off ... | Grant | A | 0.00 | 29,869 | 0 | 41,130 | 11.3 K to 41.1 K (+265.24 %) |
| Jan 04 2019 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Director | Option Exercise | M | 4.80 | 4,167 | 20,002 | 1,494,956 | |
| Jan 04 2019 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Director | Buy | M | 4.80 | 4,167 | 20,002 | 1,113,877 | 1.1 M to 1.1 M (+0.38 %) |
| Nov 05 2018 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Director | Option Exercise | A | 12.73 | 16,667 | 212,171 | 16,667 | |
| Oct 12 2018 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Director | Option Exercise | M | 2.10 | 100,000 | 210,000 | 0 | |
| Oct 12 2018 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Director | Payment of Exercise | F | 17.47 | 12,021 | 210,007 | 1,109,710 | 1.1 M to 1.1 M (-1.07 %) |
| Oct 12 2018 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Director | Buy | M | 2.10 | 100,000 | 210,000 | 1,121,731 | 1 M to 1.1 M (+9.79 %) |
| Oct 03 2018 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Director | Sell | S | 17.02 | 22,535 | 383,546 | 1,021,731 | 1 M to 1 M (-2.16 %) |
| Jul 02 2018 | KND | KINDRED HEALTHCARE ... | ACKERMAN JOEL | Director | Sell | D | 9.00 | 75,167 | 676,503 | 0 | 75.2 K to 0 (-100.00 %) |
| May 17 2018 | DVA | DAVITA INC. | ACKERMAN JOEL | Chief Financial Off ... | Option Exercise | A | 66.29 | 56,306 | 3,732,525 | 56,306 | |
| May 17 2018 | DVA | DAVITA INC. | ACKERMAN JOEL | Chief Financial Off ... | Option Exercise | A | 0.00 | 11,261 | 0 | 11,261 | |
| Nov 13 2017 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Director | Option Exercise | A | 3.21 | 16,667 | 53,501 | 16,667 | |
| May 25 2017 | KND | KINDRED HEALTHCARE ... | ACKERMAN JOEL | Director | Grant | A | 0.00 | 14,852 | 0 | 75,167 | 60.3 K to 75.2 K (+24.62 %) |
| Feb 23 2017 | DVA | DAVITA INC. | ACKERMAN JOEL | Chief Financial Off ... | Option Exercise | A | 68.89 | 145,159 | 10,000,004 | 145,159 | |
| Nov 01 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Option Exercise | A | 1.60 | 279,177 | 446,683 | 279,177 | |
| Oct 20 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Buy | P | 1.70 | 418 | 711 | 1,044,266 | 1 M to 1 M (+0.04 %) |
| Oct 20 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Buy | P | 1.69 | 381 | 644 | 1,043,848 | 1 M to 1 M (+0.04 %) |
| Oct 20 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Buy | P | 1.69 | 201 | 340 | 1,043,467 | 1 M to 1 M (+0.02 %) |
| Oct 20 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Buy | P | 1.70 | 1,000 | 1,698 | 1,043,266 | 1 M to 1 M (+0.10 %) |
| Oct 14 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Buy | P | 1.65 | 300 | 495 | 1,042,266 | 1 M to 1 M (+0.03 %) |
| Oct 14 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Buy | P | 1.66 | 1,000 | 1,658 | 1,041,966 | 1 M to 1 M (+0.10 %) |
| Oct 14 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Buy | P | 1.67 | 1,000 | 1,670 | 1,040,966 | 1 M to 1 M (+0.10 %) |
| Oct 14 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Buy | P | 1.68 | 1,000 | 1,679 | 1,039,966 | 1 M to 1 M (+0.10 %) |
| Oct 14 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Buy | P | 1.68 | 1,000 | 1,677 | 1,038,966 | 1 M to 1 M (+0.10 %) |
| Oct 14 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Buy | P | 1.67 | 1,000 | 1,670 | 1,037,966 | 1 M to 1 M (+0.10 %) |
| Oct 14 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Buy | P | 1.67 | 1,000 | 1,670 | 1,036,966 | 1 M to 1 M (+0.10 %) |
| Oct 14 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Buy | P | 1.69 | 500 | 845 | 1,035,966 | 1 M to 1 M (+0.05 %) |
| Oct 14 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Buy | P | 1.68 | 500 | 842 | 1,035,466 | 1 M to 1 M (+0.05 %) |
| Oct 07 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Buy | P | 1.64 | 5,000 | 8,200 | 1,034,966 | 1 M to 1 M (+0.49 %) |
| Oct 07 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Buy | P | 1.61 | 1,500 | 2,421 | 1,029,966 | 1 M to 1 M (+0.15 %) |
| Oct 07 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Buy | P | 1.62 | 702 | 1,137 | 1,028,466 | 1 M to 1 M (+0.07 %) |
| Oct 07 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Buy | P | 1.61 | 1,000 | 1,611 | 1,027,764 | 1 M to 1 M (+0.10 %) |
| Sep 26 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Buy | P | 1.65 | 33 | 54 | 1,026,764 | 1 M to 1 M (0.00 %) |
| Sep 21 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Buy | P | 1.73 | 1,000 | 1,729 | 1,026,731 | 1 M to 1 M (+0.10 %) |
| Sep 21 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Buy | P | 1.70 | 1,000 | 1,700 | 1,025,731 | 1 M to 1 M (+0.10 %) |
| Sep 21 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Buy | P | 1.63 | 1,000 | 1,628 | 1,024,731 | 1 M to 1 M (+0.10 %) |
| Sep 21 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Buy | P | 1.64 | 1,000 | 1,640 | 1,023,731 | 1 M to 1 M (+0.10 %) |
| Sep 21 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Buy | P | 1.63 | 1,000 | 1,627 | 1,022,731 | 1 M to 1 M (+0.10 %) |
| Sep 14 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Option Exercise | D | 4.55 | 100,765 | 458,481 | 0 | |
| Sep 14 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Option Exercise | D | 4.92 | 96,283 | 473,712 | 0 | |
| Sep 14 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Option Exercise | D | 4.92 | 16,101 | 79,217 | 0 | |
| Sep 14 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Option Exercise | D | 4.92 | 112,331 | 552,669 | 0 | |
| Sep 14 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Option Exercise | D | 4.92 | 112,331 | 552,669 | 0 | |
| Sep 14 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Option Exercise | D | 4.92 | 182,580 | 898,294 | 0 | |
| Sep 14 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Option Exercise | D | 4.92 | 182,580 | 898,294 | 0 | |
| Sep 14 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Option Exercise | A | 2.10 | 94,405 | 198,251 | 94,405 | |
| Sep 14 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Option Exercise | A | 2.10 | 88,470 | 185,787 | 88,470 | |
| Sep 14 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Option Exercise | A | 2.10 | 14,552 | 30,559 | 14,552 | |
| Sep 14 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Option Exercise | A | 2.10 | 101,521 | 213,194 | 101,521 | |
| Sep 14 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Option Exercise | A | 2.10 | 101,521 | 213,194 | 101,521 | |
| Sep 14 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Option Exercise | A | 2.10 | 150,795 | 316,670 | 150,795 | |
| Sep 14 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Option Exercise | A | 2.10 | 150,795 | 316,670 | 150,795 | |
| May 26 2016 | KND | KINDRED HEALTHCARE ... | ACKERMAN JOEL | Director | Grant | A | 0.00 | 12,356 | 0 | 60,315 | 48 K to 60.3 K (+25.76 %) |
| Nov 23 2015 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Option Exercise | A | 4.55 | 100,765 | 458,481 | 100,765 | |
| Mar 27 2015 | KND | KINDRED HEALTHCARE ... | ACKERMAN JOEL | Director | Grant | A | 0.00 | 6,416 | 0 | 47,959 | 41.5 K to 48 K (+15.44 %) |
| Mar 23 2015 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Option Exercise | A | 0.41 | 1,155,400 | 473,714 | 1,155,400 | |
| Mar 23 2015 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Option Exercise | A | 0.41 | 193,210 | 79,216 | 193,210 | |
| Mar 23 2015 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Option Exercise | A | 0.41 | 1,347,977 | 552,671 | 1,347,977 | |
| Mar 23 2015 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Option Exercise | A | 0.41 | 1,347,977 | 552,671 | 1,347,977 | |
| Mar 23 2015 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Option Exercise | A | 0.41 | 2,190,959 | 898,293 | 2,190,959 | |
| Mar 23 2015 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Option Exercise | A | 0.41 | 2,190,958 | 898,293 | 2,190,958 | |
| Mar 17 2015 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Option Exercise | A | 0.48 | 1,490,789 | 715,579 | 1,490,789 | |
| Mar 17 2015 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Buy | J | 0.00 | 70,826 | 0 | 3,643,000 | 3.6 M to 3.6 M (+1.98 %) |
| Mar 17 2015 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Buy | P | 0.00 | 2,710,526 | 0 | 3,572,174 | 861.6 K to 3.6 M (+314.57 %) |
| May 21 2004 | MRN | MEDICAL STAFFING N ... | ACKERMAN JOEL | Director | Buy | P | 5.91 | 1,900 | 11,229 | 14,525,036 | 14.5 M to 14.5 M (+0.01 %) |
| May 21 2004 | MRN | MEDICAL STAFFING N ... | ACKERMAN JOEL | Director | Buy | P | 5.77 | 35,000 | 201,950 | 14,523,136 | 14.5 M to 14.5 M (+0.24 %) |
| May 21 2004 | MRN | MEDICAL STAFFING N ... | ACKERMAN JOEL | Director | Buy | P | 5.69 | 35,000 | 199,150 | 14,488,136 | 14.5 M to 14.5 M (+0.24 %) |
Page: 1